Arbutus shareholders elect all five director nominees, approve say-on-pay and auditor at 2025 AGM

Arbutus Biopharma Corp

All five director nominees elected: Androski, Beardsley, Bishop, Gline, Hasija (avg 123M votes for).
Non-binding advisory vote on named executive officer compensation passed (122.8M for, 7.0M against).
Appointment of Ernst & Young as independent auditor for FY2025 ratified (157.7M for).
Broker non-votes (28.2M) were present on director and say-on-pay proposals.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.